BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. SIRT1, T cell receptor signaling pathway, Diabetes mellitus, Prostate, Biofuel)
Bookmark Forward

QuickView for FGF21 (gene)


Body Atlas

Most Correlated Tissues

  1. Plasma cell of spleen
  2. Skeletal muscle psoas
  3. Parotid gland
  4. Ascending colon
  5. Granulocyte-macrophage progenitor cell of bone marrow
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Social environment related disease
  2. High fat diet
  3. Chondrodysplasia
  4. Ketogenic diet
  5. General adaptation syndrome
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. hydrazine dihydrochloride
  2. shogaol
  3. COOH-terminal signal transamidase
  4. KDELR1 protein, human
  5. BODIPY
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. RPS3
  2. PPARA
  3. PGAM1
  4. COL10A1
  5. BHLHA15
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Research Progress of Fibroblast Growth Factor 21 in Fibrotic Diseases.
  2. FGF21 suppresses alcohol consumption through an amygdalo-striatal circuit.
  3. The Hepatokine FGF21 Increases the Human Spermatozoa Motility.
  4. Fibroblast Growth Factor 21 Levels Exhibit the Association With Renal Outcomes in Subjects With Type…
  5. FGF21: a promising therapeutic agent for alcoholic cardiomyopathy?†.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Modulation of Insulin Sensitivity by Betaine Upregulation of FGF21
  2. X-linked Hypophosphatemia and FGF21
  3. Regulation of FGF21 by Nutritional Challenges
  4. Association of Insulin Resistance and FGF21 on Cardiac Function in Pediatric Dilated Cardiomyopathy
  5. The Effect of Macronutrients on Fibroblast Growth Factor 21 (FGF21) Secretion
Explore Clinical Trials Results
  • Copyright © 2022 Illumina Inc. All rights reserved.